These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23167297)

  • 1. The cam-path forward.
    Kirk AD
    Am J Transplant; 2013 Jan; 13(1):9-10. PubMed ID: 23167297
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: letter to the editor on "Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review".
    Zhang X; Wang L
    Transpl Immunol; 2013 Mar; 28(2-3):72. PubMed ID: 23352934
    [No Abstract]   [Full Text] [Related]  

  • 3. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
    Morgan RD; O'Callaghan JM; Knight SR; Morris PJ
    Transplantation; 2012 Jun; 93(12):1179-88. PubMed ID: 22660659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab induction therapy in kidney transplantation.
    Kuypers DR
    Lancet; 2014 Nov; 384(9955):1649-51. PubMed ID: 25078307
    [No Abstract]   [Full Text] [Related]  

  • 6. Alemtuzumab induction therapy in kidney transplantation.
    Berghofen A; Singer T; Krüger B; Krämer BK; Benck U
    Lancet; 2015 Feb; 385(9970):770-1. PubMed ID: 25752170
    [No Abstract]   [Full Text] [Related]  

  • 7. Alemtuzumab induction therapy in kidney transplantation.
    Dhaun N; Kluth DC
    Lancet; 2015 Feb; 385(9970):770. PubMed ID: 25752171
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP
    Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alemtuzumab induction therapy in kidney transplantation - Authors' reply.
    Haynes R; Baigent C; Landray MJ; Harden P; Friend P
    Lancet; 2015 Feb; 385(9970):771. PubMed ID: 25752173
    [No Abstract]   [Full Text] [Related]  

  • 10. Transplantation: Alemtuzumab induction reduces acute rejection risk.
    Sidaway P
    Nat Rev Nephrol; 2014 Oct; 10(10):542. PubMed ID: 25112441
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic reviews of alemtuzumab in renal transplantation.
    O'Callaghan JM; Morgan RD; Knight SR; Morris PJ
    Transpl Immunol; 2013 Mar; 28(2-3):71. PubMed ID: 23352935
    [No Abstract]   [Full Text] [Related]  

  • 12. Alemtuzumab induction in pediatric kidney transplantation.
    Nguyen C; Shapiro R
    Pediatr Transplant; 2013 Jun; 17(4):319-20. PubMed ID: 23581963
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction.
    Weissenbacher A; Hautz T; Kimelman M; Oberhuber R; Ulmer H; Bösmüller C; Maglione M; Schneeberger S
    J Immunol Res; 2015; 2015():985460. PubMed ID: 26171403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy in renal transplant recipients: how convincing is the current evidence?
    Wagner SJ; Brennan DC
    Drugs; 2012 Mar; 72(5):671-83. PubMed ID: 22439670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.
    Heilman RL; Khamash HA; Smith ML; Chakkera HA; Moss AA; Reddy KS
    Clin Transplant; 2013; 27(5):772-80. PubMed ID: 23924146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.
    Uemura T; Ramprasad V; Matsushima K; Shike H; Valania T; Kwon O; Ghahramani N; Shah R; Farooq U; Khan A; Kadry Z
    Transplantation; 2011 Sep; 92(6):678-85. PubMed ID: 21841541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).
    Kirk AD; Hale DA; Mannon RB; Kleiner DE; Hoffmann SC; Kampen RL; Cendales LK; Tadaki DK; Harlan DM; Swanson SJ
    Transplantation; 2003 Jul; 76(1):120-9. PubMed ID: 12865797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding the right job for the tool: alemtuzumab and its role in renal transplantation.
    Newell KA; Cendales LC; Kirk AD
    Am J Transplant; 2008 Jul; 8(7):1363-4. PubMed ID: 18557735
    [No Abstract]   [Full Text] [Related]  

  • 20. Alemtuzumab in renal transplantation. Reviews of literature and usage in the United Kingdom.
    Chukwu CA; Spiers HVM; Middleton R; Kalra PA; Asderakis A; Rao A; Augustine T
    Transplant Rev (Orlando); 2022 Apr; 36(2):100686. PubMed ID: 35151219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.